Lee M. Nadler

发表

A cell type-specific enhancer in the human B7.1 gene regulated by NF- kappaB

G. Freeman, L. Glimcher, G. Gray, 1996, The Journal of experimental medicine.

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.

G. Freeman, L. Glimcher, L. Nadler, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.

J. Gribben, G. Freeman, J. Ritz, 1994, Science.

Isolated human follicular dendritic cells display a unique antigenic phenotype

G. Freeman, A. Freedman, L. Nadler, 1989, The Journal of experimental medicine.

Stages of B cell differentiation in human lymphoid tissue

L. Nadler, A. Bhan, S. Schlossman, 1981, The Journal of experimental medicine.

Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man.

L. Nadler, J. Lipton, D. Nathan, 1983, The Journal of clinical investigation.

The central role of follicular dendritic cells in lymphoid tissues.

L. Nadler, F. Schriever, Lee M. Nadler, 1992, Advances in immunology.

CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.

G. Freeman, D. Hafler, M. Dorf, 1992, Journal of immunology.

Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex.

G. Freeman, B. Benacerraf, L. Nadler, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Early signaling defects in human T cells anergized by T cell presentation of autoantigen

G. Freeman, D. Hafler, L. Nadler, 1992, The Journal of experimental medicine.

B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct.

G. Freeman, J. Griffin, U. Matulonis, 1996, Journal of immunology.

Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.

G. Freeman, R. Hodes, K. Hathcock, 1993, Science.

Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.

M. Cooke, D. Lenschow, C. Goodnow, 1994, Journal of immunology.

Structural and functional characterization of IL 2 receptors on activated human B cells.

D. Fisher, A. Boyd, L. Nadler, 1985, Journal of immunology.

Immunologic markers in non-Hodgkin's lymphoma.

A. Freedman, L. Nadler, Arnold S. Freedman, 1991, Hematology/oncology clinics of North America.

Immunologic heterogeneity of diffuse large cell lymphoma.

G. Pinkus, A. Freedman, D. Fisher, 1985, Blood.

Expression of Common Acute Lymphoblastic Leukemia Antigen ( CALLA ) by Lymphomas of B-Cell and T-Cell Lineage

J. Ritz, L. Nadler, A. Bhan, 2005 .

Role of B7-1 in mediating an immune response to myeloid leukemia cells.

G. Freeman, J. Griffin, U. Matulonis, 1995, Blood.

B7, a B-cell-restricted antigen that identifies preactivated B cells.

G. Freeman, A. Freedman, L. Nadler, 1987, Journal of immunology.

CD2 is involved in maintenance and reversal of human alloantigen- specific clonal anergy

J. Gribben, G. Freeman, J. Griffin, 1994, The Journal of experimental medicine.

Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA)

J. Ritz, J. Griffin, L. Nadler, 1983, The Journal of experimental medicine.

Further biochemical studies of the human B-cell differentiation antigens B1 and B2.

L. Nadler, H. Oettgen, W. van Ewijk, 1983, Hybridoma.

Hairy cell leukemia: a tumor of pre-plasma cells.

D. Fisher, A. Boyd, L. Nadler, 1985, Blood.

Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.

J. Gribben, G. Freeman, G. Gray, 1993, Proceedings of the National Academy of Sciences of the United States of America.

The gene for B7, a costimulatory signal for T-cell activation, maps to chromosomal region 3q13.3-3q21.

D. Adler, C. Disteche, J. Gribben, 1992, Blood.

Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.

A. Freedman, R. Soiffer, R. Gonin, 1993, Bone marrow transplantation.

HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

B. Dörken, A. Feller, L. Nadler, 1986, Journal of immunology.

Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro.

J. Gribben, L. Nadler, J. Schultze, 1997, Blood.

Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling

J. Barata, L. Nadler, V. Boussiotis, 2009, Leukemia.

Expression of cell surface markers after human B lymphocyte activation.

L. Nadler, S. Schlossman, P. Stashenko, 1981, Proceedings of the National Academy of Sciences of the United States of America.

A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.

L. Nadler, S. Schlossman, M. Bates, 1984, Journal of immunology.

Antigens on human plasma cells identified by monoclonal antibodies.

L. Nadler, S. Schlossman, R. Leonard, 1983, Journal of immunology.

In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.

J. Gribben, G. Pinkus, G. Freeman, 1997, Blood.